Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;31:787-794

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Wit, C.
Right arrow Articles by Pohl, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Wit, C.
Right arrow Articles by Pohl, U.

(Hypertension. 1998;31:787-794.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Nitric Oxide Opposes Myogenic Pressure Responses Predominantly in Large Arterioles In Vivo

Cor de Wit; Bernhard Jahrbeck; Christian Schäfer; Steffen-Sebastian Bolz; ; Ulrich Pohl

From the Institute of Physiology and Pathophysiology, Johannes-Gutenberg-Universität, Mainz, Germany.

Correspondence to Dr Cor de Wit, Institute of Physiology and Pathophysiology, Johannes-Gutenberg-Universität Mainz, Duesbergweg 6, D-55099 Mainz, Germany. E-mail dewit{at}mailvms.zdv.uni-mainz.de

Abstract—A myogenic vasoconstriction may amplify the effects of circulating vasoconstrictors. In cremaster arterioles, the contribution of a myogenic component to the constriction on intravenous infusion of norepinephrine (NE) or angiotensin II (Ang II) was studied. Second, the role of endothelium-derived nitric oxide (NO) in the control of these myogenic constrictions and its site of action in the resistance vascular bed was investigated. In 30 anesthetized (pentobarbital) hamsters, the cremaster was prepared for intravital microscopy, and a pneumatic vessel occluder was placed around the aorta to vary blood pressure in the hindquarter of the animal. Intravenous infusion of NE (0.5 nmol/min) increased the systemic blood pressure by 52±2 mm Hg. Simultaneously, constrictions of up to 33±6% were observed in the small arterioles (SAs; maximal inner diameter, 36 to 65 µm). The constrictions were not significantly altered by a local adrenergic blockade but were abolished when the pressure elevation in the cremaster arterioles was blocked by partial occlusion of the abdominal aorta. Diameters in large arterioles (LAs; maximal inner diameter, 65 to 127 µm), however, did not change significantly on NE infusion. Similar responses in the arterioles were observed when the local pressure was increased stepwise from 60 to 120 mm Hg by partial opening of the aortic occluder. However, after treatment of the cremaster tissue with the inhibitor of the NO synthase, NG-nitro-L-arginine (L-NNA, 30 µmol/L), a significant pressure-induced constriction of up to 16±3% occurred in LAs, whereas the magnitude of the constriction in SAs remained unchanged. L-NNA also abolished the increases in blood flow that were observed with increments in pressure in control animals. Similar results were obtained when Ang II was used to increase blood pressure. We conclude that a myogenic constriction of SAs contributes markedly to the overall response of cremaster arterioles to circulating vasoconstrictors. NO effectively opposes the myogenic response in LAs, thus preventing myogenic constrictions in a vascular region where constriction cannot be fully controlled by metabolic dilation. If this attenuating effect of NO on myogenic constriction also takes place in other organs, it might be a decisive mechanism in controlling changes of total peripheral vascular resistance elicited by vasoconstrictors.


Key Words: endothelium • angiotensin II • norepinephrine • arterioles • blood pressure • microscopy




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. B. Samora, J. C. Frisbee, and M. A. Boegehold
Increased myogenic responsiveness of skeletal muscle arterioles with juvenile growth
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2344 - H2351.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Just
Mechanisms of renal blood flow autoregulation: dynamics and contributions
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R1 - R17.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. Just and W. J. Arendshorst
Nitric oxide blunts myogenic autoregulation in rat renal but not skeletal muscle circulation via tubuloglomerular feedback
J. Physiol., December 15, 2005; 569(3): 959 - 974.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. W. G. E. VanTeeffelen, A. A. Constantinescu, H. Vink, and J. A. E. Spaan
Hypercholesterolemia impairs reactive hyperemic vasodilation of 2A but not 3A arterioles in mouse cremaster muscle
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H447 - H454.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. E. J. Lott, M. D. Herr, and L. I. Sinoway
Effects of age on brachial artery myogenic responses in humans
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2004; 287(3): R586 - R591.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Z. L. S. Brookes and S. Kaufman
Myogenic responses and compliance of mesenteric and splenic vasculature in the rat
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2003; 284(6): R1604 - R1610.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. Just, H. Ehmke, U. Wittmann, and H. R Kirchheim
Role of angiotensin II in dynamic renal blood flow autoregulation of the conscious dog
J. Physiol., January 1, 2002; 538(1): 167 - 177.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. S. Scotland, S. Chauhan, P. J.T. Vallance, and A. Ahluwalia
An Endothelium-Derived Hyperpolarizing Factor-Like Factor Moderates Myogenic Constriction of Mesenteric Resistance Arteries in the Absence of Endothelial Nitric Oxide Synthase-Derived Nitric Oxide
Hypertension, October 1, 2001; 38(4): 833 - 839.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. T. Ruschitzka, R. H. Wenger, T. Stallmach, T. Quaschning, C. de Wit, K. Wagner, R. Labugger, M. Kelm, G. Noll, T. Rulicke, et al.
Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin
PNAS, October 10, 2000; 97(21): 11609 - 11613.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. R. Nurkiewicz and M. A. Boegehold
Reinforcement of arteriolar myogenic activity by endogenous ANG II: susceptibility to dietary salt
Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H269 - H278.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Berthold, A. Just, H. R. Kirchheim, and H. Ehmke
Interaction Between Nitric Oxide and Endogenous Vasoconstrictors in Control of Renal Blood Flow
Hypertension, December 1, 1999; 34(6): 1254 - 1258.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. R. Nurkiewicz and M. A. Boegehold
Limitation of arteriolar myogenic activity by local nitric oxide: segment-specific effect of dietary salt
Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1946 - H1955.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
U. Pohl and C. de Wit
A Unique Role of NO in the Control of Blood Flow
Physiology, April 1, 1999; 14(2): 74 - 80.
[Abstract] [Full Text] [PDF]